MVLS Research Outputs
Discover and explore the research currently being undertaken across our seven research institutes in response to the Covid19 pandemic.
Institute of Biodiversity, Animal Health & Comparative Medicine
Sania, A. et al. (2022) Rapid antigen testing by community health workers for detection of SARS-CoV-2 in Dhaka, Bangladesh: a cross-sectional study. BMJ Open, (Accepted for Publication)
Vöhringer, H. S. et al. (2021) Genomic reconstruction of the SARS-CoV-2 epidemic in England. Nature, 600(7889), pp. 506-511. (doi: 10.1038/s41586-021-04069-y) (PMID:34649268) (PMCID:PMC8674138)
Faust, C. L. , Lambert, B., Kochenour, C., Robinson, A. C. and Bharti, N. (2021) Passive surveillance assesses compliance with COVID-19 behavioural restrictions in a rural US county. Epidemiology and Infection, 149(e211), (doi: 10.1017/S0950268821002107) (PMCID:PMC848503)
Nadal, D. , Abela-Ridder, B., Beeching, S., Cleaveland, S. , Cronin, K., Steenson, R. and Hampson, K. (2022) The impact of the first year of the COVID-19 pandemic on canine rabies control efforts: a mixed-methods study of observations about the present and lessons for the future. Frontiers in Tropical Diseases, (Accepted for Publication)
Olival, K. J. et al. (2020) Possibility for reverse zoonotic transmission of SARS-CoV-2 to free-ranging wildlife: a case study of bats. PLoS Pathogens, 16(9), e1008758. (doi: 10.1371/journal.ppat.1008758) (PMID:32881980) (PMCID:PMC7470399)
Meng, B. et al. (2021) Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the variant of concern lineage B.1.1.7. Cell Reports, 35(13), 109292. (doi: 10.1016/j.celrep.2021.109292) (PMID:34166617) (PMCID:PMC8185188)
McDougall, C. W., Brown, C., Thomson, C., Hanley, N. , Tully, M. A., Quilliam, R. S., Bartie, P. J., Gibson, L. and Oliver, D. M. (2020) From one pandemic to another: emerging lessons from COVID-19 for tackling physical inactivity in cities. Cities and Health, (doi: 10.1080/23748834.2020.1785165) (Early Online Publication)
Hynes, S., Armstrong, C. W., Xuan, B. B., Ankamah-Yeboah, I., Simpson, K. , Tinch, R. and Ressurreição, A. (2021) Have environmental preferences and willingness to pay remained stable before and during the global Covid-19 shock? Ecological Economics, 189, 107142. (doi: 10.1016/j.ecolecon.2021.107142)
Harvey, W. T. et al. (2021) SARS-CoV-2 variants, spike mutations and immune escape. Nature Reviews Microbiology, 19(7), pp. 409-424. (doi: 10.1038/s41579-021-00573-0) (PMID:34075212) (PMCID:PMC8167834)
Addie, D., Houe, L., Maitland, K. , Passantino, G. and Decaro, N. (2020) Effect of cat litters on feline coronavirus infection of cell culture and cats. Journal of Feline Medicine and Surgery, 22(4), pp. 350-357. (doi: 10.1177/1098612x19848167) (PMID:31094626)
Ceron, J. J., Lamy, E., Martinez-Subiela, S., Lopez-Jornet, P., Capela e Silva, F., Eckersall, P. D. and Tvarijonaviciute, A. (2020) Use of saliva for diagnosis and monitoring the SARS-CoV-2: a general perspective. Journal of Clinical Medicine, 9(5), e1491. (doi: 10.3390/jcm9051491) (PMID:32429101) (PMCID:PMC7290439)
Collier, D. A. et al. (2021) Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies. Nature, 593(7857), pp. 136-141. (doi: 10.1038/s41586-021-03412-7) (PMID:33706364)
Hanlon, P. et al. (2021) COVID-19 – exploring the implications of long-term condition type and extent of multimorbidity on years of life lost: a modelling study. Wellcome Open Research, 5, 75. (doi: 10.12688/wellcomeopenres.15849.3) (PMID:33709037) (PMCID:PMC7927210)
Da Silva Filipe, A. et al. (2021) Genomic epidemiology reveals multiple introductions of SARS-CoV-2 from mainland Europe into Scotland. Nature Microbiology, 6(1), pp. 112-122. (doi: 10.1038/s41564-020-00838-z) (PMID:33349681)
Rihn, S. J. et al. (2021) A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research. PLoS Biology, 19(2), e3001091. (doi: 10.1371/journal.pbio.3001091) (PMID:33630831) (PMCID:PMC7906417)
van Dorp, L., Shey, M. S., Ghedin, E., Michor, F., Koonin, E. V. and Hampson, K. (2021) How does large-scale genomic analysis shape our understanding of COVID variants in real time? Cell Systems, 12(2), pp. 109-111. (doi: 10.1016/j.cels.2021.01.004) (PMID:33539725) (PMCID:PMC7846266)
Hosie, M. J. et al. (2021) Detection of SARS-CoV-2 in respiratory samples from cats in the UK associated with human-to-cat transmission. Veterinary Record, 188(8), e247. (doi: 10.1002/vetr.247) (PMID:33890314) (PMCID:PMC8251078)
Li, K. K. et al. (2021) Genetic epidemiology of SARS-CoV-2 transmission in renal dialysis units - a high risk community-hospital interface. Journal of Infection, 83(1), pp. 96-103. (doi: 10.1016/j.jinf.2021.04.020) (PMID:33895226) (PMCID:PMC8061788)
Lampo, M., Hernández-Villena, J. V., Cascante, J., Vincenti-González, M. F., Forero-Peña, D. A., Segovia, M. J., Hampson, K. , Castro, J. and Grillet, M. E. (2021) Signatures of the Venezuelan humanitarian crisis in the first wave of COVID-19: fuel shortages and border migration. Vaccines, 9(7), 719. (doi: 10.3390/vaccines9070719) (PMID:34358135) (PMCID:PMC8310363)
Kronfeld-Schor, N., Stevenson, T., Nickbakhsh, S. , Schernhammer, E., Dopico, X., Dayan, T., Martinez, M. and Helm, B. (2021) Drivers of infectious disease seasonality: potential implications for COVID-19. Journal of Biological Rhythms, 36(1), pp. 35-54. (doi: 10.1177/0748730420987322) (PMID:33491541) (PMCID:PMC7924107)
Murcia, P. , Streiker, D. , Da Silva Filipe, A. , Robertson, D. , Jarrett, R. , Willett, B. , Hosie, M. , Biek, R. , Allan, K. and Weir, W. (2020) Send cat and dog samples to test for SARS-CoV-2. Veterinary Record, 186(17), p. 571. (doi: 10.1136/vr.m2019) (PMID:32451348)
Petrovan, S. O. et al. (2021) Post COVID‐19: a solution scan of options for preventing future zoonotic epidemics. Biological Reviews, 96(6), pp. 2694-2715. (doi: 10.1111/brv.12774) (PMID:34231315) (PMCID:PMC8444924)
Institute of Cancer Sciences
Pouwels, K. B. et al. (2021) Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK. Nature Medicine, 27(12), pp. 2127-2135. (doi: 10.1038/s41591-021-01548-7) (PMID:34650248) (PMCID:PMC8674129)
Lee, L. Y. W. et al. (2020) COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study. Lancet Oncology, 21(10), pp. 1309-1316. (doi: 10.1016/s1470-2045(20)30442-3) (PMID:32853557) (PMCID:PMC7444972)
Turco, F. et al. (2022) What experts think about prostate cancer management during the COVID-19 pandemic: report from the Advanced Prostate Cancer Consensus Conference 2021. European Urology, (doi: 10.1016/j.eururo.2022.02.010) (PMID:35393158) (PMCID:PMC8849852) (In Press)
Choe, K., Park, H. Y., Ikram, M., Lee, H. J., Park, T. J., Ullah, R. and Kim, M. O. (2022) Systematic review of the common pathophysiological mechanisms in COVID-19 and neurodegeneration: the role of bioactive compounds and natural antioxidants. Cells, 11(8), 1298. (doi: 10.3390/cells11081298)
Jensen, M. P., Le Quesne, J., Officer‐Jones, L., Teodòsio, A., Thaventhiran, J., Ficken, C., Goddard, M., Smith, C., Menon, D. and Allinson, K. S. J. (2021) Neuropathological findings in two patients with fatal COVID‐19. Neuropathology and Applied Neurobiology, 47(1), pp. 17-25. (doi: 10.1111/nan.12662) (PMID:32895961)
Keith, N. , Plummer, R., Coyle, V., Cameron, D., Evans, J. , Twelves, C., Palmer, D., Danson, S., Graham, D. and Welisch, G. (2021) Early Phase Cancer Research in the COVID-19 Pandemic: an ECMC North Initiative. Project Report. OSF. (doi: 10.17605/OSF.IO/6WTN2).
Pouwels, K. B. et al. (2021) Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey. Lancet Public Health, 6(1), e30-e38. (doi: 10.1016/s2468-2667(20)30282-6) (PMID:33308423) (PMCID:PMC7786000)
Duffy, C. et al. (2020) Chest drain aerosol generation in COVID-19 and emission reduction using a simple anti-viral filter. BMJ Open, 7, e000710. (doi: 10.1136/bmjresp-2020-000710) (PMID:33148778) (PMCID:PMC7643431)
McPeake, J. et al. (2021) Long-term outcomes following severe COVID-19 infection: a propensity matched cohort study. BMJ Open Respiratory Research, 8, e001080. (doi: 10.1136/bmjresp-2021-001080)
Niemi, M. E. K. et al. (2021) Mapping the human genetic architecture of COVID-19. Nature, 600(7889), pp. 472-477. (doi: 10.1038/s41586-021-03767-x) (PMID:34237774) (PMCID:PMC8674144)
McKay, S. C. et al. (2021) Impact of SARS-CoV-2 pandemic on pancreatic cancer services and treatment pathways: United Kingdom experience. HPB, 23(11), pp. 1656-1665. (doi: 10.1016/j.hpb.2021.03.003) (PMID:34544628) (PMCID:PMC7973054)
Hadjiyiannakis, D., Dimitroyannis, D., Eastlake, L., Peedell, C., Tripathi, L., Simcock, R., Vyas, A., Deutsch, E. and Chalmers, A.J. (2021) Personal view: low-dose lung radiotherapy should be evaluated as a treatment for severe COVID-19 lung disease. Clinical Oncology, 33(1), e64-e68. (doi: 10.1016/j.clon.2020.08.003) (PMID:32829986) (PMCID:PMC7427522)
Ferguson, K., Quail, N., Kewin, P. and Blyth, K. G. (2020) COVID-19 associated with extensive pulmonary arterial, intracardiac and peripheral arterial thrombosis. BMJ Case Reports, 13(8), e237460. (doi: 10.1136/bcr-2020-237460) (PMID:32747597) (PMCID:PMC7401579)
Faivre-Finn, C. et al. (2020) Reduced fractionation in lung cancer patients treated with curative-intent radiotherapy during the COVID-19 pandemic. Clinical Oncology, 32(8), pp. 481-489. (doi: 10.1016/j.clon.2020.05.001) (PMID:32405158) (PMCID:PMC7218369)
Hanna, C. R. et al. (2020) Glasgow Early Treatment Arm Favirpiravir (GETAFIX) for adults with early stage COVID-19: A structured summary of a study protocol for a randomised controlled trial. Trials, 21(935), (doi: 10.1186/s13063-020-04891-1) (PMID:33213530) (PMCID:PMC7675389)
McPeake, J. et al. (2021) Long-term outcomes following severe COVID-19 infection: a multicentre cohort study of family member outcomes. Annals of the American Thoracic Society, 18(12), pp. 2098-2101. (doi: 10.1513/AnnalsATS.202104-481RL) (PMID:34192506) (PMCID:PMC8641813)
Quinn, T. M. et al. (2022) Randomised controlled trial of intravenous nafamostat mesylate in COVID pneumonitis: Phase 1b/2a experimental study to investigate safety, Pharmacokinetics and Pharmacodynamics. EBioMedicine, 76, 103856. (doi: 10.1016/j.ebiom.2022.103856) (PMID:35152152) (PMCID:PMC8831100)
O'Cathail, S.M. , Gilbert, D.C., Sebag-Montefiore, D. and Muirhead, R. (2020) Challenges and consequences of COVID-19 in the management of anorectal cancer: coming together through social distancing. Clinical Oncology, 32(7), pp. 413-416. (doi: 10.1016/j.clon.2020.04.009) (PMID:32359847) (PMCID:PMC7184022)
Mangion, K. et al. (2020) The Chief Scientist Office cardiovascular and pulmonary imaging in SARS Coronavirus disease-19 (CISCO-19) study. Cardiovascular Research, 116(14), pp. 2185-2196. (doi: 10.1093/cvr/cvaa209) (PMID:32702087) (PMCID:PMC7454350)
Conway, D.I. et al. (2021) SARS-CoV-2 positivity in asymptomatic-screened dental patients. Journal of Dental Research, 100(6), pp. 583-590. (doi: 10.1177/00220345211004849) (PMID:33779355) (PMCID:PMC8138329)
Boyle, J. G., Walters, M. R. , Jamieson, S. and Durning, S. J. (2020) Clinical reasoning in the wild: premature closure during the COVID-19 pandemic. Diagnosis, 7(3), pp. 177-179. (doi: 10.1515/dx-2020-0061) (PMID:32710716)
Khan, K. S., Gall, L. S., Dreyer, S., McCollum, C., Chuntamongkol, R., Craig, C., MacKay, C., Macdonald, A. and Forshaw, M. (2022) Stage migration in newly diagnosed oesophago-gastric cancer during the first wave of the COVID-19 pandemic. British Journal of Surgery, (Accepted for Publication)
Stenvinkel, P., Painer, J., Shiels, P.G. , Bansal, A., Fereidouni, S., Natterson-Horowitz, B., Johnson, R.J. and Miranda, J.J. (2021) SARS-COV-2 and biomimetics: what saves the planet will save our health. Journal of Internal Medicine, 289(2), pp. 244-246. (doi: 10.1111/joim.13128) (PMID:32583447) (PMCID:PMC7361468)
Pauley, E., Drake, T. M., Sigfrid, L., Lone, N., Harrison, E. M., Baillie, J. K., Scott, J. T. , Walsh, T. S., Semple, M. G. and Docherty, A. B. (2021) Recovery from Covid-19 critical illness: a secondary analysis of the ISARIC4C CCP-UK cohort study and the RECOVER trial. Journal of the Intensive Care Society, (doi: 10.1177/17511437211052226) (Early Online Publication)
Emary, K. R. W. et al. (2021) Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial. Lancet, 397(10282), pp. 1351-1362. (doi: 10.1016/S0140-6736(21)00628-0) (PMID:33798499) (PMCID:PMC8009612)
Hanna, C. R. , Robb, K. A. , Blyth, K. G. , Jones, R. J. and Chalmers, A. J. (2021) Clinician attitudes to using low dose radiotherapy to treat COVID-19 lung disease. International Journal of Radiation Oncology, Biology, Physics, 109(4), pp. 886-890. (doi: 10.1016/j.ijrobp.2020.12.003) (PMID:33309910) (PMCID:PMC7726525)
Walker, A. S. et al. (2021) Tracking the emergence of SARS-CoV-2 alpha variant in the United Kingdom. New England Journal of Medicine, 385(27), pp. 2582-2585. (doi: 10.1056/NEJMc2103227) (PMID:34879193)
Jackson, M. R. et al. (2022) Low-dose lung radiotherapy for COVID-19 lung disease: a preclinical efficacy study in a bleomycin model of pneumonitis. International Journal of Radiation Oncology, Biology, Physics, 112(1), pp. 197-211. (doi: 10.1016/j.ijrobp.2021.08.029) (PMID:34478832) (PMCID:PMC8406661)
Bennett, S. S., Leung, H. Y. and Ahmad, I. (2021) A cohort analysis of patients receiving neoadjuvant androgen deprivation therapy prior to robot-assisted laparoscopic prostatectomy during the Covid-19 pandemic. Journal of Clinical Urology, (doi: 10.1177/20514158211022216) (Early Online Publication)
Wei, J. et al. (2021) Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom. Nature Microbiology, 6(9), pp. 1140-1149. (doi: 10.1038/s41564-021-00947-3) (PMID:34290390) (PMCID:PMC8294260)
Curtin, N., Bányai, K., Thaventhiran, J., Le Quesne, J., Helyes, Z. and Bai, P. (2020) Repositioning PARP inhibitors for SARS‐CoV‐2 infection(COVID‐19); a new multi‐pronged therapy for acute respiratory distress syndrome? British Journal of Pharmacology, 177(16), pp. 3635-3645. (doi: 10.1111/bph.15137) (PMID:32441764) (PMCID:PMC7280733)
Walker, A. S. et al. (2021) Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over time. eLife, 10, e64683. (doi: 10.7554/elife.64683) (PMID:34250907) (PMCID:PMC8282332)
Stock, S. J. et al. (2022) SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in Scotland. Nature Medicine, 28(3), pp. 504-512. (doi: 10.1038/s41591-021-01666-2) (PMID:35027756)
Jones, C. M. et al. (2020) Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus position. British Journal of Cancer, 123(5), pp. 709-713. (doi: 10.1038/s41416-020-0980-x) (PMID:32641867) (PMCID:PMC7341025)
Institute of Cardiovascular & Medical Sciences
Covid19 Cardiovascular Research
Please see our ICAMS Covid19 Cardiovascular Research pages for all current projects, publications and outputs.
Institute of Health & Wellbeing
There seems to be a problem with the publications at the moment. Please try again later.
Grants Awarded for Covid19 Research
- Chief Scientist Office. Understanding longer-term health impacts of social distancing and
behavioural interventions introduced to prevent the spread of infection in the population. Dr Katie Robb (PI) & Professor Rory O’Connor. £37,000.
- Hunt K, Stead M, Purves R, Bunn C, Gray C, Reith G, Wardle H, Dobbie F, Critchlow N, Donnachie A. Transitions to more harmful forms of gambling during Covid-19 pandemic: behaviours and targeted marketing in young people and bettors on sport. ESRC £464,387. Jun 2020-Dec 2021.
- Gray CM, O’Donnell K, Wyke S part of a Scotland-wide consortium of 33 behavioural scientists Protecting population physical & mental health during the coronavirus pandemic: A representative national weekly survey to understand changes. CSO £324,472. May 2020-Nov 2020.
- Shakespeare T, Watson N, Burns N, Pearson C, Wiseman P, Banks M and Kupar H. Disability and Covid 19. The aim of this study is to understand disabled people's experiences during the COVID-19 epidemic, barriers experienced and lessons learned for policy and practice. £390,000 ESRC COVID-19 Rapid Response research call
- Crampin A, Mwansambo C, Chauma Mwale A, Madise N, Ho A, Mwapasa V, Nyirenda T, Read J, Jewell C, MacPherson P, Price A, Amoah A. SARS-CoV-2 immunoepidemiology in Wellcome-funded urban andrural cohorts in Malawi : generating evidence to inform regional medium and long term decision making. Wellcome £249,544.00
- Hatton, C., Hastings, R, Abbott, D., Beyer, S., Bradshaw, J., Gore, N., Heslop, P., Jahoda, A., Marriot, A., Scior, K., Taggart, L., and Todd, S. Title: The impact of the COVID-19 pandemic on people with learning disabilities and factors associated with better outcomes. MRC award, £763,431 (September 2020- 2021)
- Prof Kate O’Donnell as PI; Dr Sara Macdonald and Dr David Blane as Co-Is. Title: Patient and public understanding of, and preferences for, digital tools to support the Scottish Test, Trace, Isolate, Support programme for COVID-19 infection. DHI/PHS; £30,000. (June – August 2020).
- How has Covid-19 social distancing amplified the mental health vulnerabilities of gay, bisexual and other men who have sex with men (GBM)? Dr Jamie Frankis, Reader in Health Psychology, GCU, Prof P Flowers, U. Strathclyde; Prof L McDaid, U. Glasgow; Dr D Strongylou, R Kincaid, GCU, J Heng, NHS Glasgow; T Tougher, NHS Lanarkshire; Y Kerr & Dr D Clutterbuck, NHS Lothian; Dr L Wallace, HPS; N Sparling, HIV Scotland. CSO £49,728
- Social and health impacts of COVID-19 suppression in vulnerable groups. Prof Sarah Armstrong, Dr Lucy Pickering - CSO £186,869
MRC/CSO Social and Public Health Sciences Unit
Robertson Centre for Biostatistics
The Roberson Centre for Biostatistics are involved as co-applicants/partners in the undernoted Covid19-related grants:
- UKRI NIHR - Demographic, multi-morbidity and genetic impact on myocardial involvement and its recovery from COVID-19: the COVID-HEART study - Prof Colin J Berry, Robertson Centre (Data Management, Statistics, Project Management, ECGs] – Total Grant award £620,076
- Medical Research Scotland – The influence of COVID-19 pandemic on the Scottish congenital heart disease population – Dr Mark Danton, Professor J G Cleland, Professor Alex McConnachie, Ms Sharon Kean – Total Grant Award £20,000
- Medical Research Scotland - Right Ventricular Dysfunction in Ventilated Patients with COVID-19 (COVID-RV) – Dr Ben Shelley, Professor Colin J Berry, Dr Claudia-Martina Messow – Total Grant Award £18,280
- Chief Scientists Office – Cardiovascular and Pulmonary Imaging in SARS Coronavirus disease-19 (CISCO-19) – Professor Colin J Berry, Professor Alex McConnachie, Ms Sharon Kean – Total Grant Award £47,940
- Medical Research Scotland - 3D Telemedicine: Transforming Patient Communication during Covid-19 – Dr Steven Lo, Robertson Centre [Statistics] - Total Grant Award £19,829
Additional advisory roles and outputs:
- RCB provides technical support for Professor Pell to analyse data in the Glasgow SafeHaven to inform the Health Board’s strategy on COVID-19 ‘shielding’.
- The RCB team has also created several UK national registries (supported by the British Cardiovascular Society) to capture cardiovascular complications and interventions associated with COVID-19,
- Dr Pierpaolo Pellicori (Clinical Senior Lecturer) is leading a Cochrane Rapid Review on cardiovascular complications of COVID-19.
Covid19 Advisory Roles
- Professor Andrew Gumley chairs the Scottish Government Covid-19 Mental Health Advisory Group and Professor Rory O’Connor is a member.
- Professor Rory O’Connor co-led the Academy of Medical Sciences and MQ Transforming Mental Health Position Paper published in Lancet Psychiatry on setting the mental health science research priorities for the COVID-19 pandemic.
- Professor Rory O’Connor was part of the COVID-19 International Suicide Prevention Research Collaboration which highlighted the strategic response for suicide prevention, also published in Lancet Psychiatry.
- Professor Rory O’Connor and Jack Melson worked closely with the Scottish Government on its flagship Distress Brief Intervention Programme and developed all of the intervention and training materials. In May 2020, the First Minister decided to scale up the DBI programme nationally to deal with the impact of Covid-19.
- Professor Jill Pell is a member of the Scottish Government’s Covid-19 Advisory Group and the testing strategy sub-group.
- Professor Andrew Gumley and Professor John Cleland are members of the CSO / NRS Restart Strategic Advisory Group.
- Claire Orange and Professor Julie Brittenden in RESTART group
- Professor Danny Mackay is member of the UKRI-BBSRC COVID-19 Cohort of Experts.
- Professor Kate O'Donnell is member of the Scottish Government Expert Reference Group on Ethnicity COVID-19.
- Professor Vittal Katikireddi is Co-Chair of the Scottish Government Expert Reference Group on Ethnicity COVID-19.
- Dr Janet Bouttell, Professor Olivia Wu, Professor Kate O’Donnell, Dr David Blane and Dr Bhautesh Jani are all part of the working group with SIGN and Health Improvement Scotland to produce evidence-based guidance for Primary Care.
- Dr David Ross provides COVID-19 advice and support to UK Defence, the Army and NATO and is lead researcher looking at the impact of COVID-19 lockdown and social isolation in soldiers.
- Dr Elise Whitley is a member of Public Health Scotland’s Mental Health Cell and currently contributing to priority setting for future work and advising on likely data sources for monitoring.
- Dr Eric Silverman is a member of Covid-19 Healthcare Coalition which is developing a decision-support dashboard intended to help policy-makers in the US to monitor the progress of the pandemic at the state and county level throughout the country.
- Professor Rich Mitchell and Dr Jonathan Olsen are on Public Health Scotland's Social and System Recovery: Environments and Spaces Group. Rich is leading their Evidence and Data subgroup.
The group is currently exploring the implications of the COVID-19 pandemic for open spaces, parks, streets, public spaces.
- Ms Ruth Dundas is part of The Scottish COVID-19 Response Consortium (SCRC) - a group of epidemiologists, mathematical modellers, data scientists, software developers and other scientists that have come together to develop new models to help inform the control of COVID-19.
- One of the key groups identified by RAMP to develop a wider range of pandemic models is the University of Glasgow led Scottish COVID-19 Response Consortium. SPHSU is involved in curating data to support model specification and calibration, and we will be increasingly involved in model design and programming.
- Dr Vittal Katikireddi is co-chair and Dr Rachel Thomson, Dr Theocharis Kromydas and Dr Peter Craig are members of a group convened by Public Health Scotland to advise the Scottish Government and other stakeholders (e.g. CoSLA, Social Security Scotland) on the impacts of the COVID-19 response on health and health inequalities that arise through economic and related pathways, and on actions that may mitigate negative impacts and enhance positive impacts. The group has published a briefing looking at protecting the health of the working-age population as lockdown reduces.
Other Covid19 Outputs
INS (International Neuropsychological Society) Newsletter
- Narayanan, J., Evans, J.J., & Wilson, B.A., (2020) Balint’s syndrome as a consequence of COVID-19: A case from Southern India. INS News: International Neuropsychological Society Member Newsletter, Issue 3, p27-31
- Safely returning clinically vulnerable people to work. Ewan Macdonald, honorary professor of occupational medicine, John Middleton, honorary professor of public health, Drushca Lalloo, honorary clinical senior lecturer, Trisha Greenhalgh, professor of primary care research
Public Health Scotland Report
- Flynn R, Riches E, Reid G, Rosenberg S, Niedzwiedz C. Rapid review of the impact of COVID-19 on mental health. Edinburgh: Public Health Scotland; 2020
Institute of Infection, Immunity & Inflammation
MRC-University of Glasgow Centre for Virus Research (CVR)
Please follow this link for the Centre for Virus Research's response to Covid19.
The Centre for Virus Research (CVR) has also contributed to this year's online Glasgow Science Festival 2020: Science on the Sofa.
- Professor David Robertson on the evolutionary origins of SARS-CoV-2
- Professor Emma Thomson on where SARS-CoV-2 in Scotland came from and a potential vaccine
- Dr Janet Scott on long-term health and psychosocial implications of Covid19 (#LongCovid)
- Dr Antonia Ho on understanding how Covid19 affects the body in Scotland and Malawi
- Dr Ana Da Silva Filipe on sequencing the genome of SARS-CoV-2
- Dr Agnieszka Szemiel on growing the virus in a high containment lab
There seems to be a problem with the publications at the moment. Please try again later.
Institute of Molecular, Cell & Systems Biology
Mahindra, A. et al. (2021) Peptides derived from the SARS-CoV-2 receptor binding motif bind to ACE2 but do not block ACE2-mediated host cell entry or pro-inflammatory cytokine induction. PLoS ONE, 16(11), e0260283. (doi: 10.1371/journal.pone.0260283) (PMID:34793553) (PMCID:PMC8601423)
Morgan, D. C. et al. (2021) Stapled ACE2 peptidomimetics designed to target the SARS-CoV-2 spike protein do not prevent virus internalisation. Peptide Science, 113(4), e24217. (doi: 10.1002/pep2.24217) (PMID:33615115) (PMCID:PMC7883042)
Hart, A. (2020) Cover illustration: "Lockdown" mural, Bath Street, Glasgow, by the.rebel.bear Unshackling Plastic Surgery from COVID-19. Journal of Plastic, Reconstructive and Aesthetic Surgery, 73(6), pp. 1009-1011. (doi: 10.1016/j.bjps.2020.05.082) (PMID:32553186) (PMCID:PMC7293883)
Institute of Neuroscience & Psychology
Patone, M. et al. (2021) Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection. Nature Medicine, 27(12), pp. 2144-2153. (doi: 10.1038/s41591-021-01556-7) (PMID:34697502) (PMCID:PMC8629105)
Rooksby, M. , Furuhashi, T. and McLeod, H. J. (2020) Hikikomori: a hidden mental health need following the COVID-19 pandemic. World Psychiatry, 19(3), pp. 399-400. (doi: 10.1002/wps.20804) (PMID:32931118)